TITLE

Bill Takes Aim at Drug Shortages

PUB. DATE
March 2011
SOURCE
Pharmaceutical Representative;Mar2011, Vol. 41 Issue 3, p11
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the move of U.S. Senators Amy Klobuchar and Bob Casey to introduce the Preserving Access to Life-Saving Medications Act to help address and prevent drug shortages in the country.
ACCESSION #
59218733

 

Related Articles

  • Rebates and Reform. Wechsler, JIM // Pharmaceutical Executive;Sep2011, Vol. 31 Issue 9, p12 

    Information on proposals concerning the renewal of the Prescription Drug User Fee Act (PDUFA), of the U.S., is presented.

  • House passes pharmacy accreditation policy. Egerv├íry, Alex // Pharmacy Today;May2011, Vol. 17 Issue 5, p51 

    The article presents an overview on the recommendations of the American Pharmaceutical Association (APhA) Policy Committee to develop a consensus-based and pharmacy profession-developed accreditation standards. APhA trustee Matt Osterhaus claims the need for the legislative bodies to pass a...

  • GIFTS FROM THE NORTH. Cope, Bill // Boise Weekly;12/21/2011, Vol. 20 Issue 26, p6 

    The author discusses aspects of a variety of drugs that are purchased from a foreign country and used to treat depression and anxiety both in Canada and in the U.S. He asserts that the legislation is pending in the Congress which would forbid international drug markets to be advertised in the...

  • STAKEHOLDER PERSPECTIVE: Orphan Drugs: The Potential Impact of Generic Biologics. Nair, Kavita V. // American Health & Drug Benefits;Jan2010, Vol. 3 Issue 1, p22 

    The article discusses the entry of generic biologics into the U.S. marketplace, and the potential impact. Legislation has been proposed by Rep. Henry Waxman, and the Obama administration that would allow brand-name biologics used for orphan drugs to be subject to competition from generics after...

  • Progress Made on the Path to Biosimilars. Greenwood, Jim // Pharmaceutical Technology;Oct2009, Vol. 33 Issue 10, p170 

    In this article, the author discusses the support of Biotechnology Industry Organization (BIO) on the U.S. Congress action towards the approval of the Pathways for Biosimilars Act (H.R. 1548) in the U.S. He comments that within the exclusive period, innovators can face competition against...

  • TERROR IN TRADING: SHOULD THE UNITED STATES CLASSIFY MEXICAN DRUG TRAFFICKING ORGANIZATIONS AS TERRORIST ORGANIZATIONS? JAKOVLJEVIC, BEN // Southern California Interdisciplinary Law Journal;2014, Vol. 23 Issue 2, p355 

    The article focuses on the drug policy reform in the U.S and a bill proposed in March 2011 that called on the U.S Secretary of State to designate Mexican drug trafficking organizations (MDTOs) as Foreign Terrorist Organizations (FTOs). Topics discussed include context of the conflict related to...

  • A Good Health Policy, But . . . ALLEN B. WEST AND JOHN R. GRAHAM // Investors Business Daily;7/7/2015, pA13 

    The authors discuss the 21st Century Cures Act and its implication to the pharmaceutical industry in the U.S. as of 2015. They believe that the legislative bill can help address the issues in pharmaceutical innovation, but they are critical on the mandatory funding proposal attached on it. They...

  • Drug Safety Bills on Slow Track Through Congress. Serebrov, Mari // BioWorld Today;2/27/2012, Vol. 23 Issue 38, p1 

    The article reports on the introduction of several bills in the U.S. Congress that intends to address counterfeit or adulterated drugs. In March 2012, the SAFE DOSES Act will be considered by the Senate's Judiciary Committee. Senator Patrick Leahy introduced a bill that intends to impose tougher...

  • THE PROPOSED FOOD AND DRUGS ACT: A LEGAL CRITIQUE. FISHER, MITCHELL SALEM // Law & Contemporary Problems;Dec1933, Vol. 1 Issue 1, p74 

    The article discusses several legal issues regarding a new Food and Drugs Act proposed in the U.S. The author analyzes the bill in relation to the present Food and Drugs Act and speculates on the legal technology concerning its scope, limitations, validity and effect. It is informed that the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics